Amicus Therapeutics, Inc. (FOLD)

NASDAQ: FOLD · Real-Time Price · USD

8.26

+0.10 (1.23%)

At close: Oct 8, 2025, 4:00 PM EDT

8.26

0.00 (0.00%)

After-hours: Oct 8, 2025, 4:11 PM EDT

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2017 - 2020
U.S. Revenue	232.96M	206.15M	Log In	Log In	Log In	Upgrade
Outside of U.S. Revenue	338.20M	322.15M	Log In	Log In	Log In	Upgrade
Revenue (Total)	571.16M	528.30M	Log In	Log In	Log In	Upgrade

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2017 - 2020
Galafold Revenue	480.99M	458.05M	Log In	Log In	Log In	Upgrade
Pombiliti and Opfolda Revenue	90.17M	70.24M	Log In	Log In	Log In	Upgrade
Revenue (Total)	571.16M	528.30M	Log In	Log In	Log In	Upgrade

Updated Jul 31, 2025. Data Source: Fiscal.ai.